Sunbelt Securities’s Foghorn Therapeutics FHTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.78K Hold
1,000
﹤0.01% 1694
2025
Q4
$5.4K Sell
1,000
-1
-0.1% -$5 ﹤0.01% 1617
2025
Q3
$4.89K Buy
1,001
+1
+0.1% +$5 ﹤0.01% 1640
2025
Q2
$4.72K Hold
1,000
﹤0.01% 1458
2025
Q1
$3.65K Hold
1,000
﹤0.01% 1481
2024
Q4
$4.61K Hold
1,000
﹤0.01% 1465
2024
Q3
$9.31K Hold
1,000
﹤0.01% 1302
2024
Q2
$5.75K Sell
1,000
-500
-33% -$2.98K ﹤0.01% 1373
2024
Q1
$10.1K Hold
1,500
﹤0.01% 1241
2023
Q4
$9.68K Hold
1,500
﹤0.01% 1182
2023
Q3
$7.5K Sell
1,500
-100
-6% -$771 ﹤0.01% 1222
2023
Q2
$11.3K Hold
1,600
﹤0.01% 1151
2023
Q1
$9.62K Buy
+1,600
New +$10.5K ﹤0.01% 1138
2022
Q1
Sell
-24,740
Closed -$334K 463
2021
Q4
$334K Buy
+24,740
New +$356K 0.05% 346

Other funds holding FHTX

Sunbelt Securities's FHTX Position: Q1 2026 in Review

Sunbelt Securities held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 1,000 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Sunbelt Securities first reported a position in FHTX in Q4 2021 and has held it in 14 quarters since. The position peaked at $334K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Sunbelt Securities held 1,000 shares of Foghorn Therapeutics worth $4.78K as of Q1 2026.
  • Sunbelt Securities left its Foghorn Therapeutics share count unchanged in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1694 holding.
  • Sunbelt Securities first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Sunbelt Securities's Foghorn Therapeutics position peaked at $334K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.